RESISTANT TO GRAM-POSITIVE, GRAM-NEGATIVE AND ANAEROBIC BACTERIA

Clinical trials for RESISTANT TO GRAM-POSITIVE, GRAM-NEGATIVE AND ANAEROBIC BACTERIA explained in plain language.

Never miss a new study

Get alerted when new RESISTANT TO GRAM-POSITIVE, GRAM-NEGATIVE AND ANAEROBIC BACTERIA trials appear

Sign up with your email to follow new studies for RESISTANT TO GRAM-POSITIVE, GRAM-NEGATIVE AND ANAEROBIC BACTERIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

First human test: how kidneys handle a powerful new antibiotic

Knowledge-focused Completed

This early-stage study aimed to understand how a new antibiotic combination (TQD3606) is processed by the body in people with varying levels of kidney function. It enrolled 32 adults, comparing those with healthy kidneys to those with mild, moderate, or severe kidney disease. The…

Matched conditions: RESISTANT TO GRAM-POSITIVE, GRAM-NEGATIVE AND ANAEROBIC BACTERIA

Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused

Last updated Mar 27, 2026 12:40 UTC

RESISTANT TO GRAM-POSITIVE, GRAM-NEGATIVE AND ANAEROBIC BACTERIA

Get alerted when new RESISTANT TO GRAM-POSITIVE, GRAM-NEGATIVE AND ANAEROBIC BACTERIA trials appear

First human test: how kidneys handle a powerful new antibiotic